Syndax Pharmaceuticals reported revenue of $72.79M and net income of -$49.36M for the quarter ended Jun 2026, up 91.8% year over year. This income statement covers 46 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||||||||||||||
| Revenue | 12.38M | 126.58M | 3.50M | 12.50M | 7.68M | 20.04M | 37.96M | 45.87M | 68.73M | 64.86M | 72.79M | |||||||||||||||||||||||||||||||||||
| Cost of RevenueCost of Rev | 4.93M | 8.05M | 7.85M | 8.28M | 9.59M | 11.85M | 12.12M | |||||||||||||||||||||||||||||||||||||||
| Gross Profit | 3.50M | 12.50M | 2.75M | 11.99M | 30.10M | 37.59M | 59.13M | 53.02M | 60.67M | |||||||||||||||||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 25.61M | 23.90M | 30.02M | 29.73M | 26.90M | 31.84M | 34.05M | 34.76M | 39.09M | 55.13M | 56.49M | 48.66M | 70.97M | 65.53M | 61.64M | 62.23M | 56.28M | 78.64M | 58.84M | 68.04M | ||||||||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 6.80M | 6.93M | 6.84M | 7.99M | 8.24M | 10.19M | 11.96M | 14.91M | 17.27M | 22.78M | 23.02M | 29.06M | 31.11M | 37.69M | 41.03M | 43.80M | 44.92M | 49.93M | 37.59M | 41.54M | ||||||||||||||||||||||||||
| Restructuring CostsRestructuring | 11.77M | 3.85M | 5.24M | 0.25M | 4.99M | 9.11M | 4.80M | 5.87M | ||||||||||||||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | -11.77M | -3.85M | -4.42M | 0.89M | -3.71M | -7.01M | -2.09M | 2.63M | -2.66M | |||||||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 32.41M | 30.83M | 36.86M | 37.72M | 35.14M | 42.03M | 46.02M | 49.68M | 56.35M | 77.91M | 79.51M | 77.72M | 102.08M | 104.05M | 103.80M | 107.31M | 103.30M | 131.28M | 99.07M | 112.78M | ||||||||||||||||||||||||||
| Operating IncomeOp. Inc | -20.03M | 95.75M | -36.86M | -37.72M | -35.14M | -42.03M | -46.02M | -49.68M | -56.35M | -77.91M | -79.51M | -74.22M | -89.58M | -96.36M | -83.76M | -69.35M | -57.43M | -62.55M | -34.20M | -39.99M | ||||||||||||||||||||||||||
| EBIT | -20.03M | 95.75M | -36.86M | -37.72M | -35.14M | -42.03M | -46.02M | -49.68M | -56.35M | -77.91M | -79.51M | -74.22M | -89.58M | -96.36M | -83.76M | -69.35M | -57.43M | -62.55M | -34.20M | -39.99M | ||||||||||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.65M | -0.01M | 0.65M | 0.69M | 1.75M | 0.04M | 0.04M | 0.04M | 0.07M | 0.06M | 0.09M | 0.09M | 0.02M | -0.12M | 0.00M | 0.00M | 0.00M | |||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.08M | 0.09M | -0.69M | -0.69M | 1.78M | 2.99M | 0.47M | -0.24M | 5.34M | 5.55M | -0.97M | -0.06M | 5.44M | 7.11M | 0.36M | 5.95M | 5.27M | 4.33M | -0.44M | 3.75M | ||||||||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.04M | 0.35M | 0.12M | -0.03M | -0.29M | -0.11M | -0.15M | -0.09M | -0.07M | -0.06M | -0.09M | -0.09M | 0.03M | -0.11M | -0.22M | -0.59M | -0.28M | -0.20M | -0.19M | -0.44M | ||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | -0.61M | 0.45M | -0.31M | 0.15M | 0.26M | 2.84M | 4.89M | 5.06M | 5.21M | 5.43M | 7.11M | 6.15M | 5.45M | 2.20M | -1.09M | -2.49M | -3.29M | -5.47M | -8.47M | -9.37M | ||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||||||||||||
| EBT | -20.60M | 95.85M | -38.19M | -39.11M | -35.11M | -39.09M | -45.59M | -49.95M | -51.08M | -72.42M | -80.58M | -74.36M | -84.16M | -89.13M | -83.39M | -63.41M | -52.16M | -58.22M | -34.64M | -36.25M | ||||||||||||||||||||||||||
| Profit After TaxPAT | -20.64M | 96.20M | -37.17M | -37.57M | -35.67M | -37.54M | -41.13M | -44.62M | -51.15M | -72.47M | -72.40M | -68.06M | -84.13M | -94.17M | -84.85M | -71.85M | -60.72M | -68.01M | -42.67M | -49.36M | ||||||||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -20.60M | 95.85M | -38.19M | -39.11M | -35.11M | -39.09M | -45.59M | -49.95M | -51.08M | -72.42M | -80.58M | -74.36M | -84.16M | -89.13M | -83.39M | -63.41M | -52.16M | -58.22M | -34.64M | -36.25M | ||||||||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -20.60M | 95.85M | -38.19M | -39.11M | -35.11M | -39.09M | -45.59M | -49.95M | -51.08M | -72.42M | -80.58M | -74.36M | -84.16M | -89.13M | -83.39M | -63.41M | -52.16M | -58.22M | -34.64M | -36.25M | ||||||||||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -20.60M | 95.85M | -38.19M | -39.11M | -35.11M | -39.09M | -45.59M | -49.95M | -51.08M | -72.42M | -80.58M | -74.36M | -84.16M | -89.13M | -83.39M | -63.41M | -52.16M | -58.22M | -34.64M | -36.25M | ||||||||||||||||||||||||||
| Preferred Dividend PaymentsPref Dividends | ||||||||||||||||||||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -20.60M | 95.85M | -38.19M | -39.11M | -35.11M | -39.09M | -45.59M | -49.95M | -51.08M | -72.42M | -80.58M | -74.36M | -84.16M | -89.13M | -83.39M | -63.41M | -52.16M | -58.22M | -34.64M | -36.25M | ||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.40 | 1.84 | -0.65 | -0.65 | -0.58 | -0.64 | -0.66 | -0.72 | -0.73 | -1.03 | -0.95 | -0.87 | -0.99 | -1.04 | -0.97 | -0.73 | -0.60 | -0.67 | -0.39 | -0.41 | ||||||||||||||||||||||||||
| EPS (Diluted) | -0.40 | 1.79 | -0.65 | -0.65 | -0.58 | -0.64 | -0.66 | -0.72 | -0.73 | -1.03 | -0.95 | -0.87 | -0.99 | -1.04 | -0.97 | -0.73 | -0.60 | -0.67 | -0.39 | -0.41 | ||||||||||||||||||||||||||
| Shares Outstanding | 51.96M | 52.06M | 58.98M | 60.16M | 60.67M | 60.76M | 69.44M | 69.64M | 69.86M | 70.37M | 85.21M | 85.27M | 85.43M | 85.62M | 86.17M | 86.34M | 86.62M | 86.63M | 88.26M | 88.99M | ||||||||||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 51.96M | 53.62M | 58.98M | 60.16M | 60.67M | 60.76M | 69.44M | 69.64M | 69.86M | 70.37M | 85.21M | 85.27M | 85.43M | 85.62M | 86.17M | 86.34M | 86.62M | 86.63M | 88.26M | 88.99M | ||||||||||||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 48.85M | 54.98M | 55.03M | 56.40M | 60.12M | 68.11M | 68.50M | 69.43M | 69.64M | 70.37M | 84.98M | 85.03M | 85.57M | 85.69M | 86.05M | 86.06M | 86.91M | 87.41M | 88.54M | 89.15M | ||||||||||||||||||||||||||
| EBITDA | -20.03M | 95.75M | -36.86M | -37.72M | -35.14M | -42.03M | -46.02M | -49.68M | -56.35M | -77.91M | -79.51M | -74.22M | -89.58M | -96.36M | -83.76M | -69.35M | -57.43M | -62.55M | -34.20M | -39.99M | ||||||||||||||||||||||||||
| Interest ExpensesInt Expense | 0.65M | -0.01M | 0.65M | 0.69M | 1.75M | 0.04M | 0.04M | 0.04M | 0.07M | 0.06M | 0.09M | 0.09M | 0.02M | -0.12M | 0.00M | 0.00M | 0.00M |